Why the study?
Myocardial injury is not unusual after TAVR, but its precipitating factors and prognostic outcomes required determination.
What are the predictors and prognostic implications of myocardial injury after transcatheter aortic valve replacement in patients with severe aortic stenosis?
What are the predictors and prognostic implications of myocardial injury after transcatheter aortic valve replacement in patients with severe aortic stenosis?
Postprocedural myocardial injury after TAVR is associated with older age, specific valve types, shorter coronary ostial distances, and lower GFR, and is linked to longer hospital stays and higher pacemaker implantation rates.
Post-TAVR myocardial injury may relate to root dimensions and procedural factors; leaves open whether targeted modifications alter prognosis.
Myocardial injury (MI) is not unusual after transcatheter aortic valve replacement (TAVR). To determine precipitating factors and prognostic outcomes of MI after TAVR, we retrospectively investigated relationships between MI after TAVR and aortic root dimensions, baseline patient characteristics, echocardiographic findings, and procedural features. Of 474 patients who underwent transfemoral TAVR for severe aortic stenosis in our tertiary center from June 2011 through June 2018, 188 (mean age, 77.7 ± 7.7 yr; 96 women [51%]) met the study inclusion criteria. Patients were divided into postprocedural MI (PMI) (n=74) and no-PMI (n=114) groups, in accordance with high-sensitivity troponin T levels. We found that MI risk was associated with older age (odds ratio [OR]=1.054; 95% CI, 1.013-1.098; P=0.01), transcatheter heart valve type (OR=10.207; 95% CI, 2.861-36.463; P=0.001), distances from the aortic annulus to the right coronary artery ostium (OR=0.853; 95% CI, 0.731-0.995; P=0.04) and the left main coronary artery ostium (OR=0.747; 95% CI, 0.616-0.906; P=0.003), and baseline glomerular filtration rate (OR=0.985; 95% CI, 0.970-1.000; P=0.04). Moreover, the PMI group had a longer time to hospital discharge (P=0.001) and a higher permanent pacemaker implantation rate (P=0.04) than did the no-PMI group. Our findings may enable better estimation of which patients are at higher risk of MI after TAVR and thus improve the planning and course of clinical care.
No takes yet. Share an insight, caveat, or question.
Güney et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: